Riskpilot← Back to searchSign inGet full accessMedvetsfull AB
ABActiveOrg 5567761142SolnaBusiness and other management consultancy activities · NACE 7020Est. 20090 employees
Revenue 2024
SEK 0
EBITDA margin
—
+33% vs 2023
Equity ratio
96.3%
Financial strength
Net profit 2024
SEK -13K
+35% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -14K | +33% |
| Net profit | SEK -13K | +35% |
| Total assets | SEK 81K | -12% |
| Equity | SEK 78K | -14% |
| Employees | 0 | — |
Legal name
Medvetsfull AB
Org number
5567761142
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
16 januari 2009
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall ha till föremål för sin verksamhet att direkt eller indirekt sälja tjänster för individ- och grupputveckling samt coachning för personlig utveckling.
Address
Solna
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10 | 6 | 4 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 | 3 | — | −21 | −14 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 6 | 3 | 0 | −21 | −14 |
| Net financials | — | — | — | — | — |
| Profit before tax | 6 | 3 | 0 | −20 | −13 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 6 | 3 | 0 | −20 | −13 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 117 | 118 | 118 | 92 | 81 |
| Equity | 109 | 111 | 112 | 91 | 78 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 | 7 | 6 | 1 | 3 |
| Total debt | 8 | 7 | 6 | 1 | 3 |
EBITDA margin
-1400000.0%
This company
15.8%
Market median
-8860859% vs market
20202024
Equity ratio
96.3%
This company
38.2%
Market median
+152% vs market
20202024
Return on equity
-16.7%
This company
18.4%
Market median
-191% vs market
20202024
Net profit margin
-1300000.0%
This company
8.1%
Market median
-16049483% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (2) | ||
KE Chief Auditor | Chief Auditor | 2022 – 2022 |
BR Chief Auditor | Chief Auditor | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medvetsfull AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Elisabeth Löwhagen | Chief Auditor | 0 companies |
| Birgit Ros-Marie Östberg | Chief Auditor | 0 companies |
| Karin Anette Elisabeth Wikström | Chief Executive Officer | 0 companies |
| Anna-Lena Andersson | Deputy Board Member | 0 companies |
| Karl Olof Roger Wikström | Chairman | 0 companies |